Members Only Content
Subscribe to get full access
Free Preview
The independent Alzheimer's drug developer failed to meet its primary endpoints. We are selling our shares.
The Trade Desk Recommendation Report
From the April MoneyShow Symposium, here are three trends forward-thinking investors should consider.
Crocs Recommendation Report
